Faeth Therapeutics, Inc. cotiza a 23.25 USD y tiene una capitalización bursátil de $599M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an act…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-2.84 | $-131.45 | $-3.74 |
| Estimado | $-0.71 | $-4.76 | $-0.62 | $-4.81 |
| Sorpresa | — | +40.3% | -21101.6% | +22.2% |
| Métrica | FTH | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -113.4% | -40.4% | -73.0% |
| ROA | -92.1% | -32.0% | -60.1% |
| Current Ratio | 5.06 | 2.84 | +2.22 |
| Debt / Equity | — | 0.28 | — |